Home › Funds › KVP Capital Advisors, LP › VRDN

KVP Capital Advisors, LP position in VRDN

VIRIDIAN THERAPEUTICS INC · Health Care

KVP Capital Advisors, LP reported holding 125,000 shares of VRDN (VIRIDIAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.6M, representing 2.10% of its reported portfolio and ranking #19 among its reported holdings. KVP Capital Advisors, LP has disclosed VRDN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)125.00K sh
Reported value held$2.57M
Portfolio Weight2.10%
First reportedQ1 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How KVP Capital Advisors, LP's VRDN position evolved

KVP Capital Advisors, LP first disclosed a stake in VRDN in Q1 2026 at 125,000 shares (US$2.4M). The position peaked in Q3 2026 at 125,000 shares, worth US$2.6M. Across 3 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 125,000 shares valued at US$2.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 125.00K $2.44M New
Q2 2026 125.00K $2.30M Hold
Q3 2026 125.00K $2.57M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRDN and 13F data

VRDN (VIRIDIAN THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in VRDN — the largest reported positions include Paradigm Biocapital Advisors LP (US$227.1M), Kynam Capital Management, LP (US$126.6M), Bellevue Group AG (US$123.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRDN

All VRDN fund holders →

FAQ

How long has KVP Capital Advisors, LP held VRDN?

KVP Capital Advisors, LP has disclosed VRDN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is KVP Capital Advisors, LP's current position in VRDN?

As of Q3 2026, KVP Capital Advisors, LP holds 125.00K shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $2.57M, representing 2.10% of its reported portfolio and ranking #19.

Has KVP Capital Advisors, LP been buying or selling VRDN?

In the latest 13F filing (Q3 2026), KVP Capital Advisors, LP held unchanged its position in VRDN. The position peaked in Q3 2026 at 125.00K shares.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, Bellevue Group AG, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.